Personale

Recapiti

Orario di ricevimento

Italiano

Biografia

Curriculum

Pubblicazioni

Insegnamenti

Serena PILLOZZI

Ruolo attuale:: Professore Associato
SSD:: MEDS-26/D - Scienze tecniche mediche e chirurgiche avanzate
Afferenza organizzativa:: Dipartimento di Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'

Recapiti

	0552751296
	serena.pillozzi(AT)unifi.it

Ulteriori Recapiti

	0554598254
	serena.pillozzi(AT)unifi.it

Serena PILLOZZI

Pubblicazioni

Legenda

Contributo su rivista |

Articolo su libro |

Libro |

Contributo in atti di convegno (proceeding) |

Brevetto |

Curatela | Altro

Altro |

Tesi di Dottorato

Antonuzzo, Lorenzo; Lavacchi, Daniele; Spada, Francesca; Marconcini, Riccardo; Gelsomino, Fabio; Amoroso, Vito; Cosso, Federica; Pellegrini, Elisa; Scolari, Federico; Sparano, Clotilde; Massaro, Giulia; Giommoni, Elisa; Messerini, Luca; Rossini, Daniele; Brugia, Marco; Costanzo, Francesco Di; Boni, Luca; Milione, Massimo; Pillozzi, Serena; Fazio, Nicola (2026). Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT). THE ONCOLOGIST, pp. 0-0, ISSN:1083-7159 DOI

Shtembari, Kristian; Catalano, Martina; Vascotto, Ismaela Anna; Calandrelli, Chiara; Mancini, Silvia; Pratesi, Luca; Izzi, Martina; Mela, Marinella Micol; Rossi, Virginia; Pillozzi, Serena; Rodriguez-Vida, Alejo; Aseafan, Mohamed; Nieto-Coronel, Maria Tereza; Santoni, Matteo; Antonuzzo, Lorenzo; Roviello, Giandomenico (2026). Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer. BIOMOLECULES, vol. 16, pp. 1-27, ISSN:2218-273X DOI

Giorgione, Roberta; Grasso, Daniela; Gambale, Elisabetta; Scolari, Federico; Rossi, Virginia; Maida, Fabrizio Di; Mela, Marinella Micol; Marzocchi, Barbara; Doni, Laura; Pasqui, Adriano; Minervini, Andrea; Caliman, Enrico; Serni, Sergio; Bernini, Andrea; Pillozzi, Serena; Antonuzzo, Lorenzo (2026). Serum Biomarkers in Bladder Cancer: NMR Metabolomics for Identification and Monitoring during Platinum-Based Therapy. ONCOLOGY RESEARCH, vol. 34, pp. 1-10, ISSN:1555-3906 DOI

Vascotto, Ismaela Anna; Catalano, Martina; Venturini, Jacopo; Calandrelli, Chiara; Mancini, Silvia; Pratesi, Luca; Izzi, Martina; Mela, Marinella Micol; Rossi, Virginia; Francini, Edoardo; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2026). Case Report: Niraparib–abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases. FRONTIERS IN ONCOLOGY, vol. 16, pp. 1-6, ISSN:2234-943X DOI

Paulet, Alexandra; Shtembari, Kristian; Izzi, Martina; Calandrelli, Chiara; Mancini, Silvia; Mela, Marinella Micol; Rossi, Virginia; Giorgione, Roberta; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2026). Predictive biomarkers in cancer immunotherapy for genitourinary malignancies. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, vol. 227, pp. 1-10, ISSN:1879-0461 DOI

Izzi, Martina; Lapucci, Andrea; Catalano, Martina; Vascotto, Ismaela Anna; Calandrelli, Chiara; Mancini, Silvia; Pratesi, Luca; Mela, Marinella Micol; Rossi, Virginia; Pillozzi, Serena; Koatale, Palesa Caroline; Roberts, Robin; Matthews, Diana; Cerbone, Linda; Perrella, Armando; Santoni, Matteo; Antonuzzo, Lorenzo; Roviello, Giandomenico (2026). Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention. PHARMACOLOGY & THERAPEUTICS, vol. 288, pp. 1-7, ISSN:0163-7258 DOI

Roviello, Giandomenico; Di Civita, Mattia Alberto; Santini, Daniele; Gambale, Elisabetta; Strigari, Lidia; Scagnoli, Simone; Pappalardo, Laura; Torchia, Andrea; Botticelli, Andrea; Pillozzi, Serena; Antonuzzo, Lorenzo (2026). Evaluation of Drug–Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25). ONCOLOGY AND THERAPY, vol. 14, pp. 983-993, ISSN:2366-1070 DOI

Todorovic, Nevena; Bertorello, Sara; Nannini, Giulia; Pillozzi, Serena; Bianchi, Simonetta; Ambrosio, Maria Raffaella; Niccolai, Elena; Baldi, Simone; Amedei, Amedeo (2026). Comparative Analysis of Tumor Microbiota Identifies a Metastatic-Specific Bacterial Signature, Highlighting Streptococcus spp. As the Predominant Hub across Cancers. ONCOLOGY RESEARCH, vol. 34, pp. 1-10, ISSN:1555-3906 DOI

Roviello G.; Gambale E.; Giorgione R.; Basso U.; Oliveri M.; Cremante M.; Atzori F.; Scagliarini S.; Masini C.; Baldazzi V.; Scolari F.; Mela M.M.; Lai E.; Vascotto I.A.; Rossi V.; Calandrelli C.; Rossini D.; Lavacchi D.; Serni S.; Minervini A.; Pillozzi S.; Antonuzzo L. (2026). Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study. SCIENTIFIC REPORTS, vol. 16, pp. 0-0, ISSN:2045-2322 DOI

Izzi M.; Shtembari K.; Specchiarello S.; Calandrelli C.; Mancini S.; Mela M.M.; Rossi V.; Giorgione R.; Rossini D.; Pillozzi S.; Antonuzzo L.; Roviello G. (2026). Post-ASCO 2026: resident-led highlights of the most clinically relevant studies in genitourinary oncology. FUTURE ONCOLOGY, pp. 1-5, ISSN:1479-6694 DOI

Pillozzi S.; Giommoni E.; Petroni G.; Rossini D.; Lavacchi D.; Brugia M.; Galli A.; Antonuzzo L. (2026). The KRAS targeting revolution in metastatic pancreatic cancer: insights from the landmark RASolute-302 trial and emerging allele-specific strategies at ASCO 2026. JOURNAL OF HEMATOLOGY & ONCOLOGY, vol. 19, pp. 0-0, ISSN:1756-8722 DOI

Elena Zago, Michele Citone, Letizia Canu, Lorenzo Antonuzzo, Serena Pillozzi, Elisa Pellegrini, Luisa Petrone, Mario Maggi, Clotilde Sparano (2026). Systematic review of multimodal management strategies for Insulinoma-Induced hypoglycaemia: current evidence and future directions.. ENDOCRINE, pp. 0-0, ISSN:1559-0100

Gioele Renzi; Alessandro Tubita; Lorenzo Antonuzzo; Serena Pillozzi; Marta Ferraroni; Andrea Angeli; Claudiu T. Supuran (2026). Design and Synthesis of Bendamustine-Carbonic Anhydrase Inhibitors with Antiproliferative Effects in Clear Cell Renal Cell Carcinoma. JOURNAL OF MEDICINAL CHEMISTRY, pp. 0-0, ISSN:0022-2623 DOI

Catalano, Martina; Venturini, Jacopo; Vascotto, Ismaela Anna; Sthembari, Kristian; Mancini, Silvia; Pratesi, Luca; Paulet, Alexandra; Mela, Marinella Micol; Rossi, Virginia; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2026). Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 223, pp. 1-6, ISSN:1040-8428 DOI

Roviello, Giandomenico; Catalano, Martina; Gambale, Elisabetta; Aquino, Irene De Gennaro; Lai, Eleonora; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Buti, Sebastiano; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo (2026). Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study. CLINICAL GENITOURINARY CANCER, vol. 24, pp. 1-8, ISSN:1558-7673 DOI

Roviello, Giandomenico; Gambale, Elisabetta; De Gennaro Aquino, Irene; Maruzzo, Marco; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Catalano, Martina; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo (2026). Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25. CANCER IMMUNOLOGY, IMMUNOTHERAPY, vol. 75, pp. 1-11, ISSN:1432-0851 DOI

Roviello, Giandomenico; Gambale, Elisabetta; De Gennaro Aquino, Irene; Maruzzo, Marco; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Catalano, Martina; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo (2026). Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study. FRONTIERS IN IMMUNOLOGY, vol. 17, pp. 1-11, ISSN:1664-3224 DOI

Grosso, A.A.; Cadenar, A.; Pillozzi, S.; Carli, G.; Lipparini, F.; Di Maida, F.; Pichler, R.; Krajewski, W.; Albisinni, S.; Laukhtina, E.; Mancon, S.; del Giudice, F.; Mir, M.C.; Soria, F.; Moschini, M.; Shariat, S.F.; Roupret, M.; Yuen-Chun Teoh, J.; Antonuzzo, L.; Breda, A.; Minervini, A.; Gallioli, A.; Mari, A. (2025). Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review. ACTAS UROLÓGICAS ESPAÑOLAS, vol. 49, pp. 0-0, ISSN:2173-5786 DOI

Roviello, Giandomenico; Gambale, Elisabetta; De Gennaro Aquino, Irene; Maruzzo, Marco; Messina, Carlo; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Erbetta, Elisa; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo (2025). Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25). THE ONCOLOGIST, vol. 30, pp. 1-10, ISSN:1083-7159 DOI

Suraci D, Tirloni L, Gatto C, Pillozzi S, Antonuzzo L, Taddei A, Cicchi R. (2025). Optical diagnostics of liver tumors using an autofluorescence lifetime probe. BIOMEDICAL OPTICS EXPRESS, pp. 3923-3935, ISSN:2156-7085

Defazio G, Scolari F, Fancelli S, Polvani S, Lavacchi D, Picariello L, Tubita A, Luconi M, Antonuzzo L, Galli A, Pillozzi S. (2025). Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration. FRONTIERS IN ONCOLOGY, pp. 0-0, ISSN:2234-943X

Massaro G, Paulet A, Lavacchi D, Brugia M, Rossini D, Giommoni E, Catalano M, Pillozzi S, Antonuzzo L, Roviello G. (2025). Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, pp. 0-0, ISSN:1948-5204

Massaro G, Venturini J, Rossini D, Vannini A, Brugia M, Lavacchi D, Conticello C, Valle I, Ravizza D, Pillozzi S, Antonuzzo L. (2025). Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS. CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, pp. 0-0, ISSN:1879-0461

Grasso D, Marzocchi B, Scoccianti G, Palchetti I, Campanacci DA, Antonuzzo L, Scolari F, Pillozzi S, Bernini A. (2025). Untargeted Metabolomics and Liquid Biopsy Investigation of Circulating Biomarkers in Soft Tissue Sarcoma. CANCERS, pp. 0-0, ISSN:2072-6694

Gambale E, Giorgione R, Basso U, Galli L, Fornarini G, Atzori F, Scagliarini S, Masini C, Baldazzi V, Scolari F, Mela MM, Maruzzo M, Vascotto IA, Rossi V, Rossini D, Roviello G, Lavacchi D, Serni S, Minervini A, Pillozzi S, Antonuzzo L. (2025). A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study. IN VIVO, pp. 3381-3393, ISSN:0258-851X

Tubita A, Fancelli S, Anela L, Petroni G, Caliman E, Mazzoni F, Scolari F, Napolitano B, Menicacci B, Comin CE, Voltolini L, Pillozzi S, Antonuzzo L. (2025). KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC. FRONTIERS IN ONCOLOGY, pp. 0-0, ISSN:2234-943X

LAVACCHI, DANIELE; CALIMAN, ENRICO; FANCELLI, SARA; PILLOZZI, SERENA; ANTONUZZO, LORENZO; COMIN, CAMILLA EVA; VOLTOLINI, LUCA; SCOLARI, FEDERICO; PASQUI, ADRIANO; MANNESCHI, CLARA; MAZZONI, FRANCESCA; GENSINI, FRANCESCA; PASINI, VALERIA (2025). Genetic signatures of ERCC1 and ERCC2 expression, along with SNPs variants, unveil favorable prognosis in SCLC patients undergoing platinum-based chemotherapy. ONCOLOGY RESEARCH, vol. 33, pp. 45-55, ISSN:1555-3906 DOI

Tubita, Alessandro; De Angelis, Claudia; Grasso, Daniela; Sorbi, Flavia; Castiglione, Francesca; Anela, Lorenzo; Petrella, Maria Cristina; Fambrini, Massimiliano; Scolari, Federico; Bernini, Andrea; Petroni, Giulia; Pillozzi, Serena; Antonuzzo, Lorenzo (2025). Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian Cancer. METABOLITES, vol. 16, pp. 0-0, ISSN:2218-1989 DOI

Grosso, A.A.; Cadenar, A.; Pillozzi, S.; Carli, G.; Lipparini, F.; Di Maida, F.; Pichler, R.; Krajewski, W.; Albisinni, S.; Laukhtina, E.; Mancon, S.; del Giudice, F.; Mir, M.C.; Soria, F.; Moschini, M.; Shariat, S.F.; Roupret, M.; Yuen-Chun Teoh, J.; Antonuzzo, L.; Breda, A.; Minervini, A.; Gallioli, A.; Mari, A. (2025). ADN tumoral circulante en el cáncer de vejiga músculo invasivo: una revisión sistemática. ACTAS UROLÓGICAS ESPAÑOLAS, vol. 49, pp. 1-9, ISSN:0210-4806 DOI

Cantini G, Salvianti F, Armignacco R, Propato AP, Canu L, Ercolino T, Dedonno AA, Lepri C, Mannelli M, Nesi G, Pillozzi S, Defazio G, Pinzani P, Luconi M. (2025). An innovative nuclear antigen-based approach for single-cell isolation of circulating tumor cells in adrenal cortical carcinoma. THE JOURNAL OF LIQUID BIOPSY, pp. ---, ISSN:2950-1954 DOI

Petroni G.; Scolari F.; Scoccianti G.; Palomba A.; Greto D.; Romagnoli S.; Palchetti I.; Bernini A.; Caliman E.; Polvani S.; Nozzoli F.; Menicacci B.; Nannini G.; Campanacci D.A.; Pillozzi S.; Antonuzzo L. (2025). Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma. CELL DEATH & DISEASE, vol. 16, pp. 0-0, ISSN:2041-4889 DOI

Massaro, Giulia; Lavacchi, Daniele; Innocenti, Tommaso; Polvani, Simone; Galli, Andrea; Taddei, Antonio; Petroni, Giulia; Rossini, Daniele; Pillozzi, Serena; Antonuzzo, Lorenzo (2025). Microbiome dysbiosis and KRAS-driven tumorigenesis in pancreatic cancer: implications for immune checkpoint inhibitors efficacy. JOURNAL OF THE NATIONAL CANCER CENTER, pp. 0-0, ISSN:2667-0054 DOI

Petroni, Giulia; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy. CANCER RESEARCH, vol. 84, pp. 1199-1209, ISSN:0008-5472 DOI

Catalano, Martina; Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Michelet, Marta Gatta; Mancini, Silvia; Manneschi, Clara; Shabani, Sonia; Napolitano, Brunella; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2024). Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors. SCIENTIFIC REPORTS, vol. 14, pp. 1-9, ISSN:2045-2322 DOI Accesso ONLINE all'editore

GAMBALE, ELISABETTA; VENTURI, GIULIA; GUARINO, ADRIANA; VASCOTTO, ISMAELA ANNA; PILLOZZI, SERENA; DESIDERI, ISACCO; DONI, LAURA; ANTONUZZO, LORENZO (2024). Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma. CANCER DIAGNOSIS & PROGNOSIS, vol. 4, pp. 680-683, ISSN:2732-7787 DOI

Venturini, Jacopo; Massaro, Giulia; Lavacchi, Daniele; Rossini, Daniele; Pillozzi, Serena; Caliman, Enrico; Pellegrini, Elisa; Antonuzzo, Lorenzo (2024). The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm?. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol. 204, pp. 1-13, ISSN:1040-8428 DOI

De Giorgi, Vincenzo; Silvestri, Flavia; Cecchi, Giovanni; Venturi, Federico; Zuccaro, Biancamaria; Perillo, Gabriella; Cosso, Federica; Maio, Vincenza; Simi, Sara; Antonini, Pietro; Pillozzi, Serena; Antonuzzo, Lorenzo; Massi, Daniela; Doni, Laura (2024). Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical–Dermoscopic and Histopathological Case–Control Study. CANCERS, vol. 16, pp. 1-11, ISSN:2072-6694 DOI Accesso ONLINE all'editore

Todesca, Luca Matteo; Gerke, Matthias; Bulk, Emma Etmar; Bachmann, Magdalena; Rudersdorf, Alisa; Antonuzzo, Lorenzo; Pillozzi, Serena; Düfer, Martina; Szabo, Ildiko; Schwab, Albrecht (2024). Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells. CELL DEATH DISCOVERY, vol. 10, pp. 1-13, ISSN:2058-7716 DOI

Gambale, Elisabetta; Maruzzo, Marco; Messina, Carlo; De Gennaro Aquino, Irene; Vascotto, Ismaela Anna; Rossi, Virginia; Bimbatti, Davide; Cavasin, Nicolò; Messina, Marco; Mennitto, Alessia; Rebuzzi, Sara Elena; Nasso, Cecilia; Mercinelli, Chiara; Maiorano, Brigida Anna; Fanelli, Martina; Sorarù, Mariella; Scolari, Federico; Mela, Marinella Micol; Galli, Luca; Salfi, Alessia; Rizzo, Mimma; Puglisi, Silvia; Orlando, Valentina; Fornarini, Giuseppe; Rametta, Alessandro; Giannatempo, Patrizia; Cerbone, Linda; Doni, Laura; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25). CLINICAL GENITOURINARY CANCER, vol. 22, pp. 1-11, ISSN:1558-7673 DOI

D. Suraci, E. Baria, L. Tirloni, J. L. Lagarto, S. Buccianti, C. Agostini, S. Pillozzi, L. Antonuzzo, A. Taddei, R. Cicchi (2024). Time-resolved autofluorescence imaging of freshly excised liver biopsies using an optical fiber probe. In: SPIE BiOS 2024, San Francisco, California, USA, SPIE, pp. 0-0. DOI

Suraci, D.; Baria, E.; Tirloni, L.; Lagarto, J. L.; Buccianti, S.; Agostini, C.; Pillozzi, S.; Antonuzzo, L.; Taddei, A.; Cicchi, R. (2024). Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probe. JOURNAL OF BIOPHOTONICS, pp. 1-12, ISSN:1864-063X DOI

Cosso, Federica; Lavacchi, Daniele; Messerini, Luca; Briganti, Vittorio; Castiglione, Francesca; Brugia, Marco; Berti, Valentina; Fancelli, Sara; Cianchi, Fabio; Vannini, Agnese; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma. ANTI-CANCER DRUGS, pp. 1-3, ISSN:0959-4973 DOI

Fancelli, Sara; Petroni, Giulia; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Unconventional strategy could be the future: From target to KRAS broad range treatment. HELIYON, vol. 10, pp. 1-7, ISSN:2405-8440 DOI

Lavacchi, Daniele; Roviello, Giandomenico; Guidolin, Alessia; Romano, Silvia; Venturini, Jacopo; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Pellegrini, Elisa; Brugia, Marco; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 5840-5851, ISSN:1422-0067 DOI

Sfragano P.S.; Pillozzi S.; Condorelli G.; Palchetti I. (2023). Practical tips and new trends in electrochemical biosensing of cancer-related extracellular vesicles. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, vol. 415, pp. 1087-1106, ISSN:1618-2650 DOI

Gambale, Elisabetta; Palmieri, Valeria Emma; Rossi, Virginia; Francini, Edoardo; Bonato, Adele; Salfi, Alessia; Galli, Luca; Mela, Marinella Micol; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival. CANCER DIAGNOSIS & PROGNOSIS, vol. 3, pp. 538-542, ISSN:2732-7787 DOI Accesso ONLINE all'editore

Cosso, Federica; Lavacchi, Daniele; Fancelli, Sara; Caliman, Enrico; Brugia, Marco; Rossi, Gemma; Winchler, Costanza; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer. ANTI-CANCER DRUGS, vol. 34, pp. 451-454, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Lavacchi, Daniele; Fancelli, Sara; Buttitta, Eleonora; Vannini, Gianmarco; Guidolin, Alessia; Winchler, Costanza; Caliman, Enrico; Vannini, Agnese; Giommoni, Elisa; Brugia, Marco; Cianchi, Fabio; Pillozzi, Serena; Roviello, Giandomenico; Antonuzzo, Lorenzo (2023). Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 24, pp. 1-18, ISSN:1422-0067 DOI Accesso ONLINE all'editore

Lavacchi D.; Gelmini S.; Calabri A.; Rossi G.; Simi L.; Caliman E.; Mancini I.; Salvianti F.; Petroni G.; Guidolin A.; Scolari F.; Messerini L.; Pillozzi S.; Pinzani P.; Antonuzzo L. (2023). Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients. HELIYON, vol. 9, pp. 0-0, ISSN:2405-8440 DOI

Lavacchi, Daniele; Polvani, Simone; Taddei, Antonio; Scolari, Federico; Messerini, Luca; Caliman, Enrico; Moraldi, Luca; Guidolin, Alessia; Grazi, Gian Luca; Galli, Andrea; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients. FRONTIERS IN ONCOLOGY, vol. 13, pp. 1-12, ISSN:2234-943X DOI

Catalano, Martina; Lavacchi, Daniele; Giommoni, Elisa; Shabani, Sonia; Guidolin, Alessia; Brugia, Marco; Petrioli, Roberto; Ramello, Monica; Pillozzi, Serena; Antonuzzo, Lorenzo; Roviello, Giandomenico (2023). Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI. FUTURE ONCOLOGY, vol. 19, pp. 2537-2546, ISSN:1479-6694 DOI

Caliman, Enrico; Fancelli, Sara; Petroni, Giulia; Gatta Michelet, Marta Rita; Cosso, Federica; Ottanelli, Carlotta; Mazzoni, Francesca; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo (2023). Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification. LUNG CANCER, vol. 175, pp. 88-100, ISSN:0169-5002 DOI

Antonuzzo, Lorenzo; Caliman, Enrico; Petrella, Maria Cristina; Rossi, Virginia; Mazzoni, Francesca; Grosso, Anna Maria; Fancelli, Sara; Paglialunga, Luca; Comin, Camilla; Roviello, Giandomenico; Pillozzi, Serena (2022). Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer. CURRENT CANCER DRUG TARGETS, vol. 22, pp. 0-0, ISSN:1568-0096 DOI

Gambale, Elisabetta; Boddi, Anna; Pasqui, Adriano; Campanacci, Domenico Andrea; Scoccianti, Guido; Palchetti, Ilaria; Bernini, Andrea; Antonuzzo, Lorenzo; Pillozzi, Serena (2022). Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity. CANCER TREATMENT AND RESEARCH COMMUNICATIONS, vol. 31, pp. 0-0, ISSN:2468-2942 DOI

Caliman, Enrico; Fancelli, Sara; Ottanelli, Carlotta; Mazzoni, Francesca; Paglialunga, Luca; Lavacchi, Daniele; Michelet, Marta Rita Gatta; Giommoni, Elisa; Napolitano, Brunella; Scolari, Federico; Voltolini, Luca; Comin, Camilla Eva; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy. CANCER TREATMENT AND RESEARCH COMMUNICATIONS, vol. 32, pp. 0-0, ISSN:2468-2942 DOI

Lavacchi, Daniele; Fancelli, Sara; Roviello, Giandomenico; Castiglione, Francesca; Caliman, Enrico; Rossi, Gemma; Venturini, Jacopo; Pellegrini, Elisa; Brugia, Marco; Vannini, Agnese; Bartoli, Caterina; Cianchi, Fabio; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer. FRONTIERS IN ONCOLOGY, vol. 12, pp. 1055019-1055030, ISSN:2234-943X DOI Accesso ONLINE all'editore

Giorgione, Roberta; Risaliti, Matteo; Bartolini, Ilenia; Rossi, Gemma; Pillozzi, Serena; Muiesan, Paolo; Taddei, Antonio; Antonuzzo, Lorenzo (2022). The emerging role of immunotherapy in biliary tract cancer: a review of new evidence and predictive biomarkers. IMMUNOTHERAPY, vol. 14, pp. 567-576, ISSN:1750-743X DOI

Gambale, Elisabetta; Fancelli, Sara; Caliman, Enrico; Petrella, Maria Cristina; Doni, Laura; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment. JOURNAL FOR IMMUNOTHERAPY OF CANCER, vol. 10, pp. 0-0, ISSN:2051-1426 DOI

Grasso, Daniela; Pillozzi, Serena; Tazza, Ilaria; Bertelli, Matteo; Campanacci, Domenico Andrea; Palchetti, Ilaria; Bernini, Andrea (2022). An improved NMR approach for metabolomics of intact serum samples. ANALYTICAL BIOCHEMISTRY, vol. 654, pp. 0-0, ISSN:0003-2697 DOI

Lepri, Gemma; Catalano, Martina; Bellando-Randone, Silvia; Pillozzi, Serena; Giommoni, Elisa; Giorgione, Roberta; Botteri, Cristina; Matucci-Cerinic, Marco; Antonuzzo, Lorenzo; Guiducci, Serena (2022). Systemic Sclerosis Association with Malignancy. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, pp. 0-0, ISSN:1559-0267 DOI Accesso ONLINE all'editore

Lavacchi, Daniele; Caliman, Enrico; Rossi, Gemma; Buttitta, Eleonora; Botteri, Cristina; Fancelli, Sara; Pellegrini, Elisa; Roviello, Giandomenico; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions. PHARMACOLOGY & THERAPEUTICS, vol. 237, pp. 108170-108170, ISSN:0163-7258 DOI

Fancelli, Sara; Caliman, Enrico; Mazzoni, Francesca; Paglialunga, Luca; Gatta Michelet, Marta Rita; Lavacchi, Daniele; Berardi, Rossana; Mentrasti, Giulia; Metro, Giulio; Birocchi, Ilaria; Delmonte, Angelo; Priano, Ilaria; Comin, Camilla Eva; Castiglione, Francesca; Bartoli, Caterina; Voltolini, Luca; Pillozzi, Serena; Antonuzzo, Lorenzo (2022). KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population. FRONTIERS IN ONCOLOGY, vol. 12, pp. 1-11, ISSN:2234-943X DOI

Pasqui, Adriano; Boddi, Anna; Campanacci, Domenico Andrea; Scoccianti, Guido; Bernini, Andrea; Grasso, Daniela; Gambale, Elisabetta; Scolari, Federico; Palchetti, Ilaria; Palomba, Annarita; Fancelli, Sara; Caliman, Enrico; Antonuzzo, Lorenzo; Pillozzi, Serena (2022). Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 23, pp. 0-0, ISSN:1422-0067 DOI Accesso ONLINE all'editore

Patiti, Claudia; Sfragano, Patrick Severin; Laschi, Serena; Pillozzi, Serena; Boddi, Anna; Crociani, Olivia; Bernini, Andrea; Palchetti, Ilaria (2022). Chip-Based and Wearable Tools for Isothermal Amplification and Electrochemical Analysis of Nucleic Acids. CHEMOSENSORS, vol. 10, pp. 0-0, ISSN:2227-9040 DOI

Polvani, Simone; Martignano, Filippo; Scoccianti, Guido; Pasqui, Adriano; Palomba, Anna Rita; Conticello, Silvo; Galli, Andrea; Palchetti, Ilaria; Caporalini, Chiara; Antonuzzo, Lorenzo; Campanacci, Domenico Andrea; Pillozzi, Serena (2022). Growth arrest-specific 5 lncRNA as a valuable biomarker of chemoresistance in osteosarcoma. ANTI-CANCER DRUGS, vol. 33, pp. 278-285, ISSN:0959-4973 DOI

Fancelli, S; Roviello, G; Castiglione, F; Caliman, E; Mazzoni F, null; Paglialunga L, null; Pillozzi, S; Antonuzzo, L (2022). Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol. 23, pp. 0-0, ISSN:1389-2010 DOI Accesso ONLINE all'editore

Menconi A.; Marzo T.; Massai L.; Pratesi A.; Severi M.; Petroni G.; Antonuzzo L.; Messori L.; Pillozzi S.; Cirri D. (2021). Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles. BIOMETALS, vol. 34, pp. 867-879, ISSN:0966-0844 DOI

Fancelli S.; Caliman E.; Mazzoni F.; Brugia M.; Castiglione F.; Voltolini L.; Pillozzi S.; Antonuzzo L. (2021). Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives. CANCERS, vol. 13, pp. 1-23, ISSN:2072-6694 DOI

Salvianti, Francesca; Gelmini, Stefania; Mancini, Irene; Pazzagli, Mario; Pillozzi, Serena; Giommoni, Elisa; Brugia, Marco; Di Costanzo, Francesco; Galardi, Francesca; De Luca, Francesca; Castiglione, Francesca; Messerini, Luca; Pinzani, Pamela; Antonuzzo, Lorenzo (2021). Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study. BRITISH JOURNAL OF CANCER, vol. 125, pp. 94-100, ISSN:1532-1827 DOI

Paderi, Agnese; Giorgione, Roberta; Giommoni, Elisa; Mela, Marinella Micol; Rossi, Virginia; Doni, Laura; Minervini, Andrea; Carini, Marco; Pillozzi, Serena; Antonuzzo, Lorenzo (2021). Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. CANCERS, vol. 13, pp. 1-11, ISSN:2072-6694 DOI Accesso ONLINE all'editore

Vultaggio, Alessandra; Petrella, Maria Cristina; Tomao, Federica; Nencini, Francesca; Mecheri, Valentina; Marini, Andrea; Perlato, Margherita; Vivarelli, Emanuele; De Angelis, Claudia; Ferrarini, Ilaria; Pillozzi, Serena; Matucci, Andrea; Antonuzzo, Lorenzo (2021). The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer. GYNECOLOGIC ONCOLOGY REPORT, vol. 38, pp. 1-4, ISSN:2352-5789 DOI Accesso ONLINE all'editore

Giommoni, Elisa; Giorgione, Roberta; Paderi, Agnese; Pellegrini, Elisa; Gambale, Elisabetta; Marini, Andrea; Antonuzzo, Andrea; Marconcini, Riccardo; Roviello, Giandomenico; Matucci-Cerinic, Marco; Capaccioli, David; Pillozzi, Serena; Antonuzzo, Lorenzo (2021). Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients. IMMUNO, vol. 1, pp. 253-263, ISSN:2673-5601 DOI

Bagni, Giacomo; Emmi, Giacomo; Lastraioli, Elena; Patti, Francesca Di; Silvestri, Elena; Guerriero, Angela; Pillozzi, Serena; Niccolai, Elena; Amedei, Amedeo; Emmi, Lorenzo; Prisco, Domenico; Arcangeli, Annarosa (2021). Circulating miRNome profiling data in Behçet's syndrome. DATA IN BRIEF, vol. 2021, pp. 1-8, ISSN:2352-3409 DOI

Giommoni, Elisa; Maiello, Evaristo; Vaccaro, Vanja; Rondini, Ermanno; Vivaldi, Caterina; Tortora, Giampaolo; Toppo, Laura; Giordano, Guido; Latiano, Tiziana Pia; Lamperini, Cinzia; Pillozzi, Serena; Boni, Luca; Antonuzzo, Lorenzo; Di Costanzo, Francesco (2021). Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study). CURRENT ONCOLOGY, vol. 28, pp. 1761-1772, ISSN:1198-0052 DOI Accesso ONLINE all'editore

Giommoni, Elisa; Lavacchi, Daniele; Tirino, Giuseppe; Fornaro, Lorenzo; Iachetta, Francesco; Pozzo, Carmelo; Satolli, Maria Antonietta; Spallanzani, Andrea; Puzzoni, Marco; Stragliotto, Silvia; Sisani, Michele; Formica, Vincenzo; Giovanardi, Filippo; Strippoli, Antonia; Prisciandaro, Michele; Di Donato, Samantha; Pompella, Luca; Pecora, Irene; Romagnani, Alessandra; Fancelli, Sara; Brugia, Marco; Pillozzi, Serena; De Vita, Ferdinando; Antonuzzo, Lorenzo (2021). Results of the observational prospective RealFLOT study. BMC CANCER, vol. 21, pp. 1-11, ISSN:1471-2407 DOI Accesso ONLINE all'editore

Paderi, Agnese; Fancelli, Sara; Caliman, Enrico; Pillozzi, Serena; Gambale, Elisabetta; Mela, Marinella Micol; Doni, Laura; Mazzoni, Francesca; Antonuzzo, Lorenzo (2021). Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study. CURRENT ONCOLOGY, vol. 28, pp. 3259-3267, ISSN:1718-7729 DOI Accesso ONLINE all'editore

Lottini, Tiziano; Iorio, Jessica; Lastraioli, Elena; Carraresi, Laura; Duranti, Claudia; Sala, Cesare; Armenio, Miriam; Noci, Ivo; Pillozzi, Serena; Arcangeli, Annarosa (2021). Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses. SCIENTIFIC REPORTS, vol. 11, pp. 1-17, ISSN:2045-2322 DOI

Pillozzi S.; Bernini A.; Palchetti I.; Crociani O.; Antonuzzo L.; Campanacci D.; Scoccianti G. (2021). Soft tissue sarcoma: An insight on biomarkers at molecular, metabolic and cellular level. CANCERS, vol. 13, pp. 3044-3069, ISSN:2072-6694 DOI Accesso ONLINE all'editore

Hasic Telalovic, Jasminka; Pillozzi, Serena; Fabbri, Rachele; Laffi, Alice; Lavacchi, Daniele; Rossi, Virginia; Dreoni, Lorenzo; Spada, Francesca; Fazio, Nicola; Amedei, Amedeo; Iadanza, Ernesto; Antonuzzo, Lorenzo (2021). A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy. DIAGNOSTICS, vol. 11, pp. 804-820, ISSN:2075-4418 DOI Accesso ONLINE all'editore

Paderi A.; Gambale E.; Botteri C.; Giorgione R.; Lavacchi D.; Brugia M.; Mazzoni F.; Giommoni E.; Bormioli S.; Amedei A.; Pillozzi S.; Cerinic M.M.; Antonuzzo L. (2021). Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis. MOLECULES, vol. 26, pp. 5789-5815, ISSN:1420-3049 DOI

Lavacchi D.; Roviello G.; Giommoni E.; Dreoni L.; Derio S.; Brugia M.; Amedei A.; Pillozzi S.; Antonuzzo L. (2021). Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience. CANCERS, vol. 13, pp. 3863-3890, ISSN:2072-6694 DOI

Malentacchi, Francesca; Sgromo, Chiara; Antonuzzo, Lorenzo; Pillozzi, Serena (2020). Liquid biopsy in endometrial cancer. JOURNAL OF CANCER METASTASIS AND TREATMENT, vol. 2020, pp. 1-18, ISSN:2394-4722 DOI

Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Vergoni F, Amunni G, Fambrini M, Petraglia F, Noci I, Pillozzi S (2020). Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?. REPRODUCTIVE SCIENCES, vol. 27, pp. 592-598, ISSN:1933-7205 DOI Accesso ONLINE all'editore

Malentacchia F.; Turrini I.; Zepponi F.; Fantappie G.; Sorbi F.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. (2020). Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: Predictable tool of relapse?. ANTI-CANCER DRUGS, vol. 31, pp. 1091-1095, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Fantappie G.; Malentacchi F.; Turrini I.; Sorbi F.; Castiglione F.; Vergoni F.; Ammatuna C.; Antonuzzo L.; Fambrini M.; Noci I.; Pillozzi S. (2020). Detection of PIK3CA E545A mutation in circulating tumor DNA of a patient affected by uterine carcinosarcoma. ANTI-CANCER DRUGS, vol. 31, pp. 880-883, ISSN:0959-4973 DOI Accesso ONLINE all'editore

Mazzoni, Francesca; Petreni, Paolo; Vasile, Enrico; Panebianco, Michele; Casadei-Gardini, Andrea; Negri, Francesca; Lunghi, Alice; Pillozzi, Serena; Vivaldi, Caterina; Gervasi, Erika; Frassineti, Giovanni Luca; Messerini, Luca; Jocollé, Genny; Bisagni, Alessandra; Antonuzzo, Lorenzo; Rossi, Giulio (2020). ROS1 rearrangements are uncommon in biliary tract cancers. ONCOLOGY LETTERS, vol. 20, pp. 1-7, ISSN:1792-1074 DOI Accesso ONLINE all'editore

Lavacchi D.; Pellegrini E.; Palmieri V.E.; Doni L.; Mela M.M.; Di Maida F.; Amedei A.; Pillozzi S.; Carini M.; Antonuzzo L. (2020). Immune checkpoint inhibitors in the treatment of renal cancer: Current state and future perspective. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 21, pp. 1-21, ISSN:1661-6596 DOI

Meoni, Giulia; Giommoni, Elisa; Petreni, Paolo; Pillozzi, Serena; Mazzoni, Francesca; Pellegrini, Elisa; Brugia, Marco; Lunghi, Alice; Muto, Andrea; Antonuzzo, Lorenzo (2020). Somatostatin analogs in pregnant patients with neuroendocrine tumor. ANTI-CANCER DRUGS, vol. 31, pp. 1096-1098, ISSN:1473-5741 DOI Accesso ONLINE all'editore

Damiano Cirri, Maria Giulia Fabbrini, Lara Massai, Serena Pillozzi, Annalisa Guerri, Alessio Menconi, Luigi Messori, Tiziano Marzo, Alessandro Pratesi (2019). Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin. BIOMETALS, pp. 1-10, ISSN:0966-0844 DOI

Petroni G.; Stefanini M.; Pillozzi S.; Crociani O.; Becchetti A.; Arcangeli A. (2019). Data describing the effects of the Macrolide Antibiotic Clarithromycin on preclinical mouse models of Colorectal Cancer. DATA IN BRIEF, vol. 26, pp. 104406-104410, ISSN:2352-3409 DOI Accesso ONLINE all'editore

Tiziano Marzo, Lara Massai, Alessandro Pratesi, Matteo Stefanini, Damiano Cirri, Francesca Magherini, Matteo Becatti, Ida Landini, Stefania Nobili, Enrico Mini, Olivia Crociani, Annarosa Arcangeli, Serena Pillozzi, Tania Gamberi, Luigi Messori (2019). Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer. ACS MEDICINAL CHEMISTRY LETTERS, vol. 10 (4), pp. 656-660, ISSN:1948-5875, American Chemical Society: DOI Accesso ONLINE all'editore

Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi (2019). The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma. SCIENTIFIC REPORTS, vol. 9, pp. 0-0, ISSN:2045-2322 DOI Accesso ONLINE all'editore

Lastraioli E.; Pillozzi S.; Mari A.; Tellini R.; Duranti C.; Baldazzi V.; Venturini S.; Minervini A.; Lapini A.; Nesi G.; Carini M.; Arcangeli A. (2019). hERG1 and CA IX expression are associated with disease recurrence in surgically resected clear cell renal carcinoma. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, pp. 1-7, ISSN:0748-7983 DOI Accesso ONLINE all'editore

Lastraioli, E.; Tellini, R.; Mari, A.; Pillozzi, S.; Fiore, A.; Venturini, S.; Scelzi, S.; Lapini, A.; Minervini, A.; Carini, M.; Nesi, G.; Arcangeli, A. (2019). hERG1 potassium channel expression predicts survival in clear-cell renal cell carcinoma: A pilot study with a long-term follow up. EUROPEAN UROLOGY. SUPPLEMENTS, vol. 18, pp. e3357-0, ISSN:1569-9056 DOI

Pillozzi S.; Bernini A.; Spiga O.; Lelli B.; Petroni G.; Bracci L.; Niccolai N.; Arcangeli A. (2019). Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias. ONCOLOGY REPORTS, vol. 41, pp. 312-324, ISSN:1021-335X DOI Accesso ONLINE all'editore

Marzo, Tiziano; Pratesi, Alessandro; Cirri, Damiano; Pillozzi, Serena; Petroni, Giulia; Guerri, Annalisa; Arcangeli, Annarosa; Messori, Luigi; Gabbiani, Chiara (2018). Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation. INORGANICA CHIMICA ACTA, vol. 470, pp. 318-324, ISSN:0020-1693 DOI Accesso ONLINE all'editore

Louka A, Matlahov I , Giuntini S , Cerofolini L , Cavallo A , Pillozzi S , Ravera E , Fragai M , Arcangeli A , Ramamoorthy A , Goobes G , Luchinat C (2018). Engineering l-asparaginase for spontaneous formation of calcium phosphate bioinspired microreactors.. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, vol. 20, pp. 12719-12726, ISSN:1463-9084 DOI

Masala E, Valencia-Martinez A, Pillozzi S, Rondelli T, Brogi A, Sanna A, Gozzini A, Arcangeli A, Dello Sbarba P, Santini V (2018). Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures.. ONCOTARGET, vol. 9, pp. 10561-10571, ISSN:1949-2553 DOI

Sorbi F, Projetto E, Turrini I, Baroni G, Pillozzi S, Ghizzoni V, Vergoni F, Castiglione F, Malentacchi F, Fambrini M, Noci I (2018). Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Immunohistochemical Score Associated with Poor Prognosis in Endometrial Cancer Patients.. BIOMED RESEARCH INTERNATIONAL, vol. 2018, pp. 1-1, ISSN:2314-6141 DOI Accesso ONLINE all'editore

Pillozzi, Serena; D'Amico, Massimo; Bartoli, Gianluca; Gasparoli, Luca; Petroni, Giulia; Crociani, Olivia; Marzo, Tiziano; Guerriero, Angela; Messori, Luigi; Severi, Mirko; Udisti, Roberto; Wulff, Heike; Chandy, K George; Becchetti, Andrea; Arcangeli, Annarosa* (2018). The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells. BRITISH JOURNAL OF CANCER, vol. 118, pp. 200-212, ISSN:0007-0920 DOI Accesso ONLINE all'editore

Malentacchi F, Turrini I, Sorbi F, Projetto E, Castiglione F, Fambrini M, Petraglia F, Pillozzi S, Noci I (2018). Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer. ONCOLOGY REPORTS, vol. 41, pp. 1-15, ISSN:1021-335X DOI Accesso ONLINE all'editore

Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A (2017). Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration.. FRONTIERS IN ENDOCRINOLOGY, vol. 8, pp. 1-10, ISSN:1664-2392 DOI Accesso ONLINE all'editore

Becchetti, Andrea; Crescioli, Silvia; Zanieri, Francesca; Petroni, Giulia; Mercatelli, Raffaella; Coppola, Stefano; Gasparoli, Luca; D'Amico, Massimo; Pillozzi, Serena; Crociani, Olivia; Stefanini, Matteo; Fiore, Antonella; Carraresi, Laura; Morello, Virginia; Manoli, Sagar; Brizzi, Maria Felice; Ricci, Davide; Rinaldi, Mauro; Masi, Alessio; Schmidt, Thomas; Quercioli, Franco; Defilippi, Paola; Arcangeli, Annarosa (2017). The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression. SCIENCE SIGNALING, vol. 10, pp. eaaf3236-13, ISSN:1937-9145 DOI Accesso ONLINE all'editore

Cirri, D.; Pillozzi, S.; Gabbiani, C.; Tricomi, J.; Bartoli, G.; Stefanini, M.; Michelucci, E.; Arcangeli, A.; Messori, L; Marzo, T. (2017). PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features. DALTON TRANSACTIONS, vol. 46, pp. 3311-3317, ISSN:1477-9226 DOI Accesso ONLINE all'editore

Pratesi, Alessandro; Cirri, Damiano; Đurović, Mirjana D; Pillozzi, Serena; Petroni, Giulia; Bugarčić, Živadin D; Messori, Luigi (2016). New gold carbene complexes as candidate anticancer agents. BIOMETALS, vol. 29, pp. 905-911, ISSN:0966-0844 DOI Accesso ONLINE all'editore

Battistin, F.; Scaletti, F.; Balducci, G.; Pillozzi, S.; Arcangeli, A.; Messori, L; Alessio, E. (2016). Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties. JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 160, pp. 180-188, ISSN:0162-0134 DOI Accesso ONLINE all'editore

Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A. (2016). Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels. BLOOD CANCER JOURNAL, vol. 6, pp. e423-e427, ISSN:2044-5385 DOI Accesso ONLINE all'editore

Massai, Lara; Pratesi, Alessandro; Bogojeski, Jovana; Banchini, Marco; Pillozzi, Serena; Messori, Luigi; Bugarčić, Živadin D (2016). Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes. JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 165, pp. 1-6, ISSN:0162-0134 DOI

Noci, Ivo; Sorbi, Flavia; Mannini, Luca; Projetto, Elisabetta; Pillozzi, Serena; Ghizzoni, Viola; Lottini, Tiziano; Moncini, Daniela; Baroni, Gianna; Mungai, Francesco; Arcangeli, Annarosa; Fambrini, Massimiliano (2016). LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer. FRONTIERS IN ONCOLOGY, vol. 6, pp. 1-5, ISSN:2234-943X DOI Accesso ONLINE all'editore

Marzo, Tiziano; Bartoli, Gianluca; Gabbiani, Chiara; Pescitelli, Gennaro; Severi, Mirko; Pillozzi, Serena; Michelucci, Elena; Fiorini, Benedetta; Arcangeli, Annarosa; Quiroga, Adóracion G.; Messori, Luigi (2016). Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles. BIOMETALS, vol. 29, pp. 535-542, ISSN:0966-0844 DOI Accesso ONLINE all'editore

Gabbiani, Chiara; Pratesi, Alessandro; Marchetti, Lorella; Casini, Angela; Leoni, Piero; Pillozzi, Serena; Crociani, Olivia; Bartoli, Gianluca; Messori, Luigi (2016). Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells. JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 163, pp. 318-322, ISSN:0162-0134 DOI Accesso ONLINE all'editore

Marzo, Tiziano; Pillozzi, Serena; Hrabina, Ondrej; Kasparkova, Jana; Brabec, Viktor; Arcangeli, Annarosa; Bartoli, Gianluca; Severi, Mirko; Lunghi, Alessandro; Totti, Federico; Gabbiani, Chiara; Quiroga, Adóracion G; Messori, Luigi (2015). cis-Pt I2(NH3)2: a reappraisal. DALTON TRANSACTIONS, vol. 44, pp. 14896-14905, ISSN:1477-9234 DOI Accesso ONLINE all'editore

L Gasparoli; M D'Amico; M Masselli; S Pillozzi; R Caves; R Khuwaileh; W Tiedke; K Mugridge; A Pratesi; J Mitcheson; G Basso; A Becchetti; A Arcangeli (2015). The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity. MOLECULAR PHARMACOLOGY, pp. 183-196, ISSN:0026-895X DOI

Brunetti, Jlenia; Pillozzi, Serena; Falciani, Chiara; Scali, S; Lozzi, L; Pini, A; Arcangeli, A; Menichetti, S; Bracci, L; Depau, L; Tenori, E (2015). Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug. SCIENTIFIC REPORTS, vol. 5, pp. 1-9, ISSN:2045-2322 DOI Accesso ONLINE all'editore

Massai, Lara; Fernández-Gallardo, Jacob; Guerri, Annalisa; Arcangeli, Annarosa; Pillozzi, Serena; Contel, María; Messori, Luigi (2015). Design, synthesis and characterisation of new chimeric ruthenium(ii)-gold(i) complexes as improved cytotoxic agents. DALTON TRANSACTIONS, vol. 44, pp. 11067-11076, ISSN:1477-9226 DOI Accesso ONLINE all'editore

S Pillozzi; L Gasparoli; M Stefanini; M Ristori; M D'Amico; E Alessio; F Scaletti; A Becchetti; A Arcangeli; L Messori (2014). NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels. DALTON TRANSACTIONS, vol. 43, pp. 12150-12150, ISSN:1477-9226 DOI

Crociani O; Lastraioli E; Boni L; Pillozzi S; Romoli MR; D'Amico M; Stefanini M; Crescioli S; Taddei A; Bencini L; Bernini M; Farsi M; Beghelli S; Scarpa A; Messerini L; Tomezzoli A; Vindigni C; Morgagni P; Saragoni L; Giommoni E; Gasperoni S; Di Costanzo F; Roviello F; De Manzoni G; Bechi P; Arcangeli A. (2014). hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications. CLINICAL CANCER RESEARCH, pp. 1502-1512, ISSN:1078-0432 DOI Accesso ONLINE all'editore

Bernini, Andrea; Henrici De Angelis, Lucia; Morandi, Edoardo; Spiga, Ottavia; Santucci, Annalisa; Assfalg, Michael; Molinari, Henriette; Pillozzi, Serena; Arcangeli, Annarosa; Niccolai, Neri (2014). Searching for protein binding sites from Molecular Dynamics simulations and paramagnetic fragment-based NMR studies. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, vol. 1844, pp. 561-566, ISSN:1570-9639 DOI

Chiu, M; Tardito, S.; Pillozzi, S.; Arcangeli, A.; Armento, A.; Uggeri, J.; Missale, G.; Bianchi, M.G.; Barilli, A.; Dall'Asta, V.; Campanini, N.; Silini, E.M.; Fuchs, J.; Armeanu-Ebinger, S.; Bussolati, O. (2014). Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts. BRITISH JOURNAL OF CANCER, vol. 111, pp. 1159-1167, ISSN:1532-1827 DOI

Pillozzi, S.; Accordi, B.; Rebora, P.; Serafin, V.; Valsecchi, M.G.; Basso, G.; Arcangeli, A. (2014). Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups. LEUKEMIA, vol. 28, pp. 1352-1355, ISSN:0887-6924 DOI Accesso ONLINE all'editore

O Crociani; F Zanieri; S Pillozzi; E Lastraioli; M Stefanini; A Fiore; A Fortunato; M D'Amico; M Masselli; E De Lorenzo; L Gasparoli; M Chiu; O Bussolati; A Becchetti; A Arcangeli (2013). hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer. SCIENTIFIC REPORTS, vol. 3, pp. 3308-3321, ISSN:2045-2322 DOI

Pillozzi S;Fortunato A;De Lorenzo E;Borrani E;Giachi M;Scarselli G;Arcangeli A;Noci I (2013). Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model.. FRONTIERS IN ONCOLOGY, vol. 3, pp. 1-7, ISSN:2234-943X DOI

Marika Masselli;Pasquale Laise;Giulia Tonini;Duccio Fanelli;Serena Pillozzi;Valentina Cetica;Martina Da Ros;Iacopo Sardi;Anna Maria Buccoliero;Maurizio Aricò;Lorenzo Genitori;Andrea Becchetti;Annarosa Arcangeli (2012). Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas. FRONTIERS IN ONCOLOGY, vol. 2, pp. 1-11, ISSN:2234-943X DOI Accesso ONLINE all'editore

Arcangeli, A.; Pillozzi, S.; Becchetti, A. (2012). Targeting ion channels in leukemias: A new challenge for treatment. CURRENT MEDICINAL CHEMISTRY, vol. 19, pp. 683-696, ISSN:0929-8673 DOI

Serena Pillozzi; Marika Masselli; Marinella Veltroni (2012). Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis. BLOOD, vol. 120, pp. 1222-1222, ISSN:0006-4971

Marika Masselli; Serena Pillozzi; Massimo D'Amico (2012). Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias. BLOOD, vol. 120, pp. 1506-1506, ISSN:0006-4971

Serena Pillozzi;Andrea Becchetti (2012). Ion Channels in Hematopoietic and Mesenchymal Stem Cells. STEM CELLS INTERNATIONAL, vol. 2012, pp. 217910-217919, ISSN:1687-9678 DOI

S.Pillozzi; M.Masselli; E.De Lorenzo; B.Accordi; E.Cilia; O.Crociani; A.Amedei; M.Veltroni; M.D’Amico; G.Basso; A.Becchetti; D.Campana; A.Arcangeli (2011). Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.. BLOOD, vol. 117, pp. 902-914, ISSN:0006-4971 DOI

Arcangeli A.; Zanieri F.; Crociani O.; Pillozzi S.; Mercatelli R.; Quercioli F.; Carloni A.; Pavone F. S.; Becchetti A.; Defilippi P. (2010). The complex between the beta1 integrin and hERG1 potassium channels as a new molecular target in antineoplastic therapy. EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, vol. 8, pp. 59-59, ISSN:1359-6349

A. Arcangeli; A. Becchetti; S. Pillozzi; M. Masselli.; E. De Lorenzo. (2010). Method and kit for the prevention and/or the monitoring of the chemioresistance of leukaemia forms. Numero: 102010901807760; EP2498773 NOI PER VOI ONLUS

S.Pillozzi; A.Arcangeli (2010). Physical and functional interaction between integrins and hERG1 channels in cancer cells.. In: Andrea Becchetti, Annarosa Arcangeli. Integrins and Ion Channels, pp. 55-67 Springer, ISBN:978-144196065-8. DOI

P Fortunato; S. Pillozzi; A. Tamburini; L. Pollazzi; A. Franchi; A. La Torre; A. Arcangeli (2010). Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.. BMC CANCER, vol. 10(1), pp. 504-508, ISSN:1471-2407 DOI

Arcangeli A.; Becchetti A.; Pillozzi S.; Masselli M.; De Lorenzo E. (2010). New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias. Numero: RM2010A000048 NOI PER VOI ONLUS

A. Becchetti; S. Pillozzi; R. Morini; E. Nesti; A. Arcangeli (2010). International Review Of Cell and Molecular Biology. amsterdam: Elsevier, ISBN:9780123743756

Arcangeli A; Crociani O; Lastraioli E; Masi A; Pillozzi S; Becchetti A. (2009). Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. CURRENT MEDICINAL CHEMISTRY, vol. 16, pp. 66-93, ISSN:0929-8673 DOI

Serena Pillozzi; Marika Masselli; Emanuele De Lorenzo (2009). Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels.. BLOOD, vol. 114, pp. 1-2, ISSN:0006-4971

L.Guasti;O.Crociani;E.Redaelli;S.Pillozzi;S.Polvani;M.Masselli;T.Mello;A.Galli;A.Amedei;RS.Wymore;E.Wanke;A.Arcangeli (2008). Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells.. MOLECULAR AND CELLULAR BIOLOGY, vol. 28, pp. 5043-5060, ISSN:0270-7306 DOI Accesso ONLINE all'editore

Noci I.; Pillozzi S.; Lastraioli E.; Dabizzi S.; Giachi M.; Borrani E.; Wimalasena J.; Taddei G.L.; Scarselli G.; Arcangeli A. (2008). hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer. GYNECOLOGIC ONCOLOGY, vol. 111, pp. 496-501, ISSN:0090-8258 DOI

C. Becchi; S. Pillozzi; L. P. Fabbri; M. Al Malyan; C. Cacciapuoti; C. Della Bella; M. Nucera; M. Masselli; S. Boncinelli; A. Arcangeli; A. Amedei (2008). The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis.. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, vol. 21, pp. 697-705, ISSN:0394-6320

S.Pillozzi; M.F.Brizzi; P.A.Bernabei; B.Bartolozzi; R.Caporale; V.Basile; V.Boddi; L.Pegoraro; A.Becchetti; A.Arcangeli (2007). VEGFR-1 (FLT-1), beta1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.. BLOOD, vol. 110, pp. 1238-1250, ISSN:0006-4971

S. PILLOZZI; M. BRIZZI; P. BERNABEI; B. BARTOLOZZI; R. CAPORALE; V. BASILE; V. BODDI; L. PEGORARO; A. BECCHETTI; A. ARCANGELI; (2007). VEGFR-1(FTL-1), betal integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcome.. BLOOD, vol. 110, pp. 1238-1250, ISSN:0006-4971, American Society of Hematology:1900 M Street Northwest, Suite 200:Washington, DC 20036:(800)633-4931, (202)776-0544, EMAIL: publishing@hematology.org, ash@hematology.org, INTERNET: http://www.hematology.org, Fax: (202)776-0551:

Holmes, O; Pillozzi, S; Deakin, J A; Carafoli, F; Kemp, L; Butler, P J G; Lyon, M; Gherardi, E (2007). Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains. JOURNAL OF MOLECULAR BIOLOGY, vol. 367, pp. 395-408, ISSN:0022-2836 DOI Accesso ONLINE all'editore

Annarosa Arcangeli; Serena Pillozzi; Maria F Brizzi (2006). VEGFR-1 (FLY-1), b(1) integrin and hERGK(+) channel form a macromolecular signaling complex in acute myeloid leukemia cells. BLOOD, vol. 108, pp. 670A-670A1, ISSN:0006-4971

Benedetta Accordi; Serena Pillozzi; Dell'Orto Campo (2005). c-Met oncogene enhances Fas-mediated apoptosis in B-ALL t(12;21) cells. BLOOD, vol. 106, pp. 1-2, ISSN:0006-4971

CHERUBINI A; HOFMANN G; PILLOZZI S; GUASTI L; O. CROCIANI; CILIA E; BALZI M; DEGANI S; DI STEFANO P; DEFILIPPI P; WANKE E; BECCHETTI A; OLIVOTTO M; WYMORE RS; ARCANGELI A (2005). herg1 channels are physically linked to beta 1 integrins and modulate adhesion-dependent signalling.. MOLECULAR BIOLOGY OF THE CELL, vol. 16, pp. 2972-2983, ISSN:1059-1524 DOI

A. ARCANGELI; A. BECCHETTI; A. CHERUBINI; O. CROCIANI; L. GUASTI; G. HOFMANN; S. PILLOZZI; M. OLIVOTTO; E. WANKE; P. DEFILIPPI (2004). Physical and functional interaction between integrins and hERG potassium channels.. BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 32, pp. 826-827, ISSN:0300-5127 Accesso ONLINE all'editore

Polvani S.; Masi A.; Pillozzi S.; Gragnani L.; Crociani O.; Olivotto M.; Becchetti A.; Wanke E.; Arcangeli A. (2003). Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3. GENE EXPRESSION PATTERNS, vol. 3, pp. 767-776, ISSN:1567-133X DOI

Cherubini A.; Pillozzi S.; Hofmann G.; Crociani O.; Guasti L.; Lastraioli E.; Polvani S.; Masi A.; Becchetti A.; Wanke E.; Olivotto M.; Arcangeli A. (2002). HERG K+ channels and β1 integrins interact through the assembly of a macromolecular complex. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 973, pp. 559-561, ISSN:0077-8923 DOI Accesso ONLINE all'editore

CHERUBINI A; PILLOZZI S; HOFMANN G; CROCIANI O; GUASTI L; LASTRAIOLI E; POLVANI S; MASI A; BECCHETTI A; WANKE E; OLIVOTTO M; A. ARCANGELI (2002). HERG K+ channels and beta1 integrins interact through the assembly of a macromolecular complex.. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, vol. 973, pp. 559-561, ISSN:0077-8923 Accesso ONLINE all'editore

S. PILLOZZI; M. BALZI; O. CROCIANI; A. CHERUBINI; L. GUASTI; B. BARTOLOZZI; A. BECCHETTI; E. WANKE; M. OLIVOTTO; L. PEGORARO; A. ARCANGELI; M. BRIZZI; P. BERNABEI (2002). HERG potassium channels are constitutively expressed in primary human acute myeloid leukemias and regulate cell proliferation of normal and leukemic hemopoietic progenitors. LEUKEMIA, vol. 16(9), pp. 1791-1798, ISSN:0887-6924 Accesso ONLINE all'editore

Pillozzi S.; Balzi M.; Brizzi M.F.; Becchetti A.; Crociani O.; Faraoni P.; Cherubini A.; Guasti L.; Hofmann G.; Lastraioli E.; Masi A.; Polvani S.; Bartolozzi B.; Bernabei P.A.; Pegoraro L.; Wanke E.; Olivotto M.; Arcangeli A. (2001). I farmaci antiaritmici di III classe bloccano la proliferazione cellulare in cellule leucemiche inibendo i canali di K+ di tipo herg.. In: 21° Congresso Nazionale della Società Italiana di Chemioterapia, Firenze, Dicembre, pp. 129-129.

HOFMANN G.; BERNABEI P.A.; CROCIANI O.; CHERUBINI A.; GUASTI L.; PILLOZZI S.; LASTRAIOLI E.; POLVANI S.; BARTOLOZZI B.; SOLAZZO V.; GRAGNANI L.; DEFILIPPI P.; ROSATI B.; WANKE E.; OLIVOTTO M.; A. ARCANGELI (2001). HERG K+ channels activation in during beta1 integrin-mediated adhesion to fibronectin induces an upregulation of alfavbeta3 integrin in the preosteoclastic leukemia cell line FLG-29.1.. THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, pp. 4923-4931, ISSN:0021-9258 Accesso ONLINE all'editore

Hofmann G;Bernabei PA;Crociani O;Cherubini A;Guasti L;Pillozzi S;Lastraioli E;Polvani S;Bartolozzi B;Solazzo V;Gragnani L;Defilippi P;Rosati B;Wanke E;Olivotto M;Arcangeli A (2001). HERG K+ channels activation during beta(1) integrin-mediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1.. THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 276, pp. 4923-4931, ISSN:0021-9258 DOI

Giuliano Frangioni;Gianfranco Borgioli;Stefano Bianchi;Serena Pillozzi (2000). Relationships between hepatic melanogenesis and respiratory conditions in the newt,Triturus carnifex. JOURNAL OF EXPERIMENTAL ZOOLOGY, vol. 287, pp. 120-127, ISSN:0022-104X DOI

G. Frangioni; G. Borgioli ; S. Bianchi; S. Pillozzi. (2000). Relationships between hepatic melanogenesis and respiratory conditions in the newt.. JOURNAL OF EXPERIMENTAL ZOOLOGY, vol. 287, pp. 120-127, ISSN:1097-010X